KnowTheStock
Log inCreate free account

Zimmer Biomet Holdings Inc

ZBH
S&P 500Electromedical and Electrotherapeutic Apparatus Manufacturing · NEW YORK STOCK EXCHANGE INC.
$91.24last close · market cap 17.59 Billion
Compare with…
46.3SCORE / 100
Our verdictHOLDModerate Growth and StableQtr Ending 2026-06-30

Why Hold

Income statement and cash flow are moderate; balance sheet is weak.

Next earnings: 2026-11-04 (BMO), EPS Forecast: $1.89

What is strong
  • Debt Ratio is 0.45
  • Total Debt to Total Assets Ratio is 0.33
What to watch
  • Revenue Growth is 8.62%
  • Operating Income Growth is -4.42%
  • Net Income Growth is -2.04%
  • Earnings Per Share (EPS) Growth is 0.49%
  • Net Margin is 9.48%
  • Current Asset to Current Liability Ratio is 1.69
  • Current Debt to Net Income Ratio is 6.06
  • Cash from Operations Growth is 4.83%
  • Capital Expenditure is High
  • Net Increase in Cash is Negative

What changed

Score by quarter

Upgraded from Sell to Hold in the Jun 2026 quarter: 46.0 → 46.3 (+0.3). This quarter: +0.3.

30405060Sep 2022Jun 2026

What the score is made of

Income statement51.7 -0.2
Balance sheet33.9 -0.0
Cash flow50.3 +2.6

Change vs previous quarter.

Key numbers · latest quarter

Revenue (TTM)8.51 Billion8.62 % growth
EPS4.110.49 % growth
Profit margin9.48 %Profit per $1 of sales
P-E ratio—Not available
Market cap17.59 BillionShares × price
Debt-equity ratio0.59Leverage
Dividend0.96Per share, annual
Next earnings2026-11-04BMO · EPS forecast $1.89
Better viewed in landscape mode.
Unless specified, all values are in USD Millions. Data extracted from SEC Filing and are subject to processing and input errors.

About Zimmer Biomet Holdings Inc

Founded in 1927 and headquartered in Warsaw, Indiana, Zimmer Biomet is a global leader in musculoskeletal healthcare. It designs, manufactures and markets orthopedic reconstructive products; sports medicine, biologics, extremities and trauma products; office-based technologies; spine, craniomaxillofacial and thoracic products; dental implants; and related surgical products.

CEO
Bryan Hanson
Employees
18,000
Sector
Manufacturing
Exchange
NEW YORK STOCK EXCHANGE INC.
www.zimmerbiomet.com

Similar stocks

Loading…